Helicobacter pylori eradication in gastric mucosa-associated lymphoid tissue lymphoma: Results of a 196-patient series

Leukemia and Lymphoma

Volumn 47, Issue 10, 2006, Pages 2110-2114

  Wündisch, Thomas ^a   Mösch, Christoph ^b   Neubauer, Andreas ^a   Stolte, Manfred ^b  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b INSTITUTE OF PATHOLOGY   (Germany)

Author keywords

Eradication; Helicobacter pylori; Lymphoma; Mucosa associated lymphoid tissue

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGE DISTRIBUTION; AGED; AGING; ARTICLE; CANCER LOCALIZATION; CANCER REGRESSION; CANCER RELAPSE; CANCER STAGING; CANCER SURVIVAL; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; FEMALE; FOLLOW UP; FREQUENCY ANALYSIS; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MINIMAL RESIDUAL DISEASE; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; OUTCOMES RESEARCH; OVERALL SURVIVAL; PATIENT SELECTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSPECTIVE STUDY; STOMACH LYMPHOMA;

ADULT; AGED; AGED, 80 AND OVER; ANTI-INFECTIVE AGENTS; FEMALE; GASTRIC MUCOSA; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; LYMPHOMA, MUCOSA-ASSOCIATED LYMPHOID TISSUE; MALE; MIDDLE AGED; REMISSION INDUCTION; STOMACH; STOMACH NEOPLASMS; TIME FACTORS; TREATMENT OUTCOME;

EID: 33750428592     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.1080/10428190600783536     Document Type: Article

References (24)

1. Du, M and Isaccson, P. (2002) Gastric MALT lymphoma: From aetiology to treatment Lancet Oncol, 3, pp. 97-104.
2. Stolte, M and Bayerdorffer, E and Morgner, A and Alpen, B and Wundisch, T and Thiede, C and (2002) Helicobacter and gastric MALT lymphoma Gut, 50(Suppl 3), pp. III19-III24.
3. Raderer, M and Streubel, B and Wohrer, S and Hafner, M and Chott, A. (2006) Successful antibiotic treatment of Helicobacter pylori negative gastric MALT lymphomas Gut, 55(5), pp. 616-618.
4. Wohlfart, S and Sebinger, D and Gruber, P and Buch, J and Polgar, D and Krupitza, G and (2004) FAS (CD95) mutations are rare in gastric MALT lymphoma but occur more frequently in primary gastric diffuse large B-cell lymphoma Am J Pathol, 164, pp. 1081-1089.
5. Hellmig, S and Fischbach, W and Goebeler-Kolve, M and Folsch, U and Hampe, J and Schreiber, S. (2005) Association study of a functional Toll-like receptor 4 polymorphism with susceptibility to gastric mucosa-associated lymphoid tissue lymphoma Leuk Lymphoma, 46, pp. 869-972.
6. Hellmig, S and Vollenberg, S and Goebeler-Kolve, M and Fischbach, W and Hampe, J and Folsch, U and (2004) IL-1 gene cluster polymorphisms and development of primary gastric B-cell lymphoma in Helicobacter pylori infection Blood, 104, pp. 2994-2995.
7. de Mascarel, A and Ruskone-Fourmestraux, A and Lavergne-Slove, A and Megraud, F and Dubus, P and Merlio, J. (2005) Clinical, histological and molecular follow-up of 60 patients with gastric marginal zone lymphoma of mucosa-associated lymphoid tissue Virchows Arch, 446, pp. 219-224.
8. Savio, A and Franzin, G and Wotherspoon, A and Zamboni, G and Negrini, R and Buffoli, F and (1996) Diagnosis and posttreatment follow-up of Helicobacter pylori-positive gastric lymphoma of mucosa-associated lymphoid tissue: Histology, polymerase chain reaction, or both? Blood, 87, pp. 1255-1260.
9. Montalban, C and Santon, A and Boixeda, D and Redondo, C and Alvarez, I and Calleja, J and (2001) Treatment of low grade gastric mucosa-associated lymphoid tissue lymphoma in stage I with Helicobacter pylori eradication. Long-term results after sequential histologic and molecular follow-up Haematologica, 86, pp. 609-617.
10. de Jong, D and Vyth-Dreese, F and Dellemijn, T and Verra, N and Ruskone-Fourmestraux, A and Lavergne-Slove, A and (2001) Histological and immunological parameters to predict treatment outcome of Helicobacter pylori eradication in low-grade gastric MALT lymphoma J Pathol, 193, pp. 318-324.
11. Bertoni, F and Conconi, A and Capella, C and Motta, T and Giardini, R and Ponzoni, M and (2002) Molecular follow-up in gastric mucosa-associated lymphoid tissue lymphomas: Early analysis of the LY03 cooperative trial Blood, 99, pp. 2541-2544.
12. Fischbach, W and Goebeler-Kolve, M and Dragosics, B and Greiner, A and Stolte, M. (2004) Long term outcome of patients with gastric marginal zone B cell lymphoma of mucosa associated lymphoid tissue (MALT) following exclusive Helicobacter pylori eradication therapy: Experience from a large prospective series Gut, 53, pp. 34-37.
13. Wundisch, T and Thiede, C and Morgner, A and Dempfle, A and Gunther, A and Liu, H and (2005) Long-term follow-up of gastric MALT lymphoma after Helicobacter pylori eradication J Clin Oncol, 23, pp. 8018-8024.
14. Montalban, C and Santon, A and Redondo, C and Garcia-Cosio, M and Boixeda, D and Vazquez-Sequeiros, E and (2005) Long-term persistence of molecular disease after histological remission in low-grade gastric MALT lymphoma treated with H. pylori eradication. Lack of association with translocation t(11;18): A 10-year updated follow-up of a prospective study Ann Oncol, 16, pp. 1539-1544.
15. Copie-Bergman, C and Gaulard, P and Lavergne-Slove, A and Brousse, N and Flejou, J and Dordonne, K and (2003) Proposal for a new histological grading system for post-treatment evaluation of gastric MALT lymphoma Gut, 52, pp. 1656.
16. de Jong, D and Boot, H and van Heerde, P and Hart, G and Taal, B. (1997) Histological grading in gastric lymphoma: Pretreatment criteria and clinical relevance Gastroenterology, 112, pp. 1466-1474.
17. Ruskone-Fourmestraux, A and Lavergne, A and Aegerter, P and Megraud, F and Palazzo, L and de Mascarel, A and (2001) Predictive factors for regression of gastric MALT lymphoma after anti-Helicobacter pylori treatment Gut, 48, pp. 297-303.
18. Raderer, M and Vorbeck, F and Formanek, M and Osterreicher, C and Valencak, J and Penz, M and (2000) Importance of extensive staging in patients with mucosa-associated lymphoid tissue (MALT)-type lymphoma Br J Cancer, 83, pp. 454-457.
19. de Jong, D and Aleman, B and Taal, B and Boot, H. (1999) Controversies and consensus in the diagnosis, work-up and treatment of gastric lymphoma: An international survey Ann Oncol, 10, pp. 275-280.
20. Ruskone-Fourmestraux, A and Aegerter, P and Delmer, A and Brousse, N and Galian, A and Rambaud, J. (1993) Primary digestive tract lymphoma: A prospective multicentric study of 91 patients. Groupe d'Etude des Lymphomes Digestifs Gastroenterology, 105, pp. 1662-1671.
21. Thieblemont, C and Berger, F and Dumontet, C and Moullet, I and Bouafia, F and Felman, P and (2000) Mucosa-associated lymphoid tissue lymphoma is a disseminated disease in one third of 158 patients analyzed Blood, 95, pp. 802-806.
22. Datta, Y and Kampalath, B and Binion, D. (2004) Rituximab-induced remission of a lymphoma Leuk Lymphoma, 45, pp. 1297-1299.
23. Schmidt, W and Schmitz, N and Sonnen, R. (2004) Conservative management of gastric lymphoma: The treatment option of choice Leuk Lymphoma, 45, pp. 1847-1852.
24. Koch, P and Probst, A and Berdel, W and Willich, N and Reinartz, G and Brockmann, J and (2005) Treatment results in localized primary gastric lymphoma: Data of patients registered within the German multicenter study (GIT NHL 02/96) J Clin Oncol, 23, pp. 7050-7059.